Iovance Biotherapeutics (IOVA)
8.79
+0.09 (1.03%)
Upcoming Events
Latest Headlines
Iovance Biotherapeutics to Present at Upcoming Conferences
September 4, 2026 8:00 AM - StreetInsider
Iovanace Biotherapeutics (IOVA) PT Raised to $10 at TD Cowen
August 25, 2026 7:38 AM - StreetInsider
TD Cowen Assumes Iovanace Biotherapeutics (IOVA) at Buy
August 22, 2026 7:55 AM - StreetInsider
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 21, 2026 5:15 PM - StreetInsider
Iovanace Biotherapeutics (IOVA) PT Raised to $7 at UBS
August 20, 2026 6:03 AM - StreetInsider
Iovanace Biotherapeutics (IOVA) PT Raised to $11 at Mizuho
August 18, 2026 6:36 AM - StreetInsider
Form 4 IOVANCE BIOTHERAPEUTICS, For: Aug 10 Filed by: Kirby Daniel Gordon
August 12, 2026 5:30 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Aug 06 Filed by: Roche Corleen M.
August 10, 2026 5:30 PM - SEC Filing
Form SCHEDULE 13G IOVANCE BIOTHERAPEUTICS, Filed by: STATE STREET CORP
August 7, 2026 9:57 AM - SEC Filing
Iovanace Biotherapeutics (IOVA) PT Raised to $8 at Citizens
August 7, 2026 8:13 AM - StreetInsider
Iovanace Biotherapeutics (IOVA) PT Raised to $13 at Barclays
August 7, 2026 4:54 AM - StreetInsider
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Aug 06
August 6, 2026 5:31 PM - SEC Filing
Why Investors Are Watching These Healthcare Movers
August 6, 2026 12:32 PM - StreetInsider
Iovanace Biotherapeutics (IOVA) PT Raised to $7 at TD Cowen
August 6, 2026 10:58 AM - StreetInsider
Form 10-Q IOVANCE BIOTHERAPEUTICS, For: Jun 30
August 6, 2026 9:16 AM - SEC Filing
Iovance Biotherapeutics (IOVA) Tops Q2 EPS by 2c
August 6, 2026 7:32 AM - StreetInsider
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Aug 06
August 6, 2026 7:05 AM - SEC Filing
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
August 6, 2026 7:01 AM - StreetInsider
Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026
July 30, 2026 8:00 AM - StreetInsider
Form SCHEDULE 13G/A IOVANCE BIOTHERAPEUTICS, Filed by: BlackRock, Inc.
July 28, 2026 4:47 PM - SEC Filing
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 17, 2026 5:15 PM - StreetInsider
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 30
July 2, 2026 5:02 PM - SEC Filing
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
June 19, 2026 5:15 PM - StreetInsider
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: WEISER MICHAEL
June 18, 2026 5:17 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Dukes Iain D.
June 18, 2026 5:17 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Countouriotis Athena
June 18, 2026 5:16 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Maynard Ryan D
June 18, 2026 5:16 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Puri Raj K.
June 18, 2026 5:15 PM - SEC Filing
Form S-8 IOVANCE BIOTHERAPEUTICS,
June 18, 2026 5:05 PM - SEC Filing
Form S-8 IOVANCE BIOTHERAPEUTICS,
June 18, 2026 5:04 PM - SEC Filing
Iovance Biotherapeutics (IOVA) files mixed shelf
June 18, 2026 4:32 PM - StreetInsider
Form S-3ASR IOVANCE BIOTHERAPEUTICS,
June 18, 2026 4:32 PM - SEC Filing
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 04
June 10, 2026 5:01 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 05 Filed by: Vogt Frederick G
June 9, 2026 5:03 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 05 Filed by: GRAF FINCKENSTEIN FRIEDRICH
June 9, 2026 5:01 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 05 Filed by: Puri Raj K.
June 9, 2026 5:01 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 05 Filed by: BILINSKY IGOR
June 9, 2026 5:00 PM - SEC Filing
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 8, 2026 9:01 AM - Globe NewsWire
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 8, 2026 9:01 AM - StreetInsider
Full Article List
